Edition:
United States

Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,020.00GBp
8 Dec 2017
Change (% chg)

67.50 (+7.09%)
Prev Close
952.50
Open
956.50
Day's High
1,020.00
Day's Low
956.50
Volume
1,100,355
Avg. Vol
1,172,972
52-wk High
2,346.00
52-wk Low
906.50

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 13 1,942.29 1,970.29 1,922.00 2,295.54
Year Ending Dec-18 13 1,974.06 2,066.00 1,904.66 2,549.71
Earnings (per share)
Year Ending Dec-17 13 0.96 1.06 0.88 1.44
Year Ending Dec-18 13 0.94 1.16 0.75 1.84
LT Growth Rate (%) 2 24.45 28.80 20.10 20.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 19.90 32.13 35.51
P/E High - Last 5 Yrs. 35.25 40.67 45.27
P/E Low - Last 5 Yrs. 18.48 23.64 24.24
Beta 1.39 0.92 0.91
Price to Sales (TTM) 1.68 3.92 5.83
Price to Book (MRQ) 1.35 4.88 5.68
Price to Tangible Book (MRQ) 4.39 5.74 7.26
Price to Cash Flow (TTM) 9.11 23.07 24.44
% Owned Institutions -- 0.85 1.39

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg 1.02 2.17 2.05
Dividend 5 Year Growth Rate 20.16 4.28 5.23
Payout Ratio(TTM) 47.59 47.28 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1.47 6.31 6.82
Sales (TTM) vs TTM 1 Yr. Ago 21.70 5.18 5.65
Sales - 5 Yr. Growth Rate 16.26 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 12.55 7.15 7.23
EPS (TTM) vs TTM 1 Yr. Ago -17.66 -- --
EPS - 5 Yr. Growth Rate 10.34 9.89 10.90
Capital Spending - 5 Yr. Growth Rate 19.49 15.17 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.24 2.49 2.54
Current Ratio (MRQ) 1.90 3.51 3.56
LT Debt to Equity (MRQ) 31.48 10.90 13.23
Total Debt to Equity (MRQ) 36.07 17.04 19.24
Interest Coverage (TTM) 6.18 49.98 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 52.22 55.14 54.80
Gross Margin - 5 Yr. Avg. 53.79 52.29 52.40
EBITD Margin (TTM) 31.23 -- --
EBITD - 5 Yr. Avg 30.00 18.39 15.52
Operating Margin (TTM) 14.57 14.77 6.76
Operating Margin - 5 Yr. Avg. 20.93 14.38 11.03
Pre-Tax Margin (TTM) 11.56 15.22 7.58
Pre-Tax Margin - 5 Yr. Avg. 17.95 14.69 11.44
Net Profit Margin (TTM) 8.61 11.39 3.81
Net Profit Margin - 5 Yr. Avg. 13.83 11.02 7.73
Effective Tax Rate (TTM) 25.55 24.35 24.25
Effective Tax Rate - 5 Yr. Avg. 22.95 23.46 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 175,816 952,857,028 858,823,705
Net Income/Employee (TTM) 15,136 111,290,090 100,224,560
Receivable Turnover (TTM) 3.36 5.92 6.12
Inventory Turnover (TTM) 1.87 2.73 3.55
Asset Turnover (TTM) 0.44 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 3.80 11.89 11.35
Return on Assets - 5 Yr. Avg. 8.86 12.90 12.32
Return on Investment (TTM) 4.67 15.10 14.47
Return on Investment - 5 Yr. Avg. 12.32 16.88 16.13
Return on Equity (TTM) 6.88 16.59 16.06
Return on Equity - 5 Yr. Avg. 16.70 17.87 17.32
  1 Year 3 Year 5 Year
Sales % 35.42 12.62 16.26
EPS (TTM) % -47.17 -14.79 10.34
Dividend % 1.66 17.01 20.16
Note: Units in Millions of US Dollars

Performance for Hikma Pharmaceuticals PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.82 3.34 99 64
13 Week -14.29 -14.72 49 23
26 Week -37.46 -36.72 26 36
52 Week -40.04 -44.47 30 24
YTD -46.12 -48.64 22 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 34.73%
# of Holders: 225
Total Shares Held: 83,571,407
3 Mo. Net Change: 2,856,975
# New Positions: 15
# Closed Positions: 20
# Increased Positions: 63
# Reduced Positions: 55
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.